Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation

Last updated: April 3, 2025
Sponsor: Masimo Corporation
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

N/A

Treatment

Philips FAST SpO2 with Masimo Pulse Oximetry Sensors

Clinical Study ID

NCT06148623
CIP-1088
  • Ages 18-50
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation.

Eligibility Criteria

Inclusion

Inclusion Criteria (Eligible Subjects):

  • Subject is 18 to 50 years of age.

  • Subject weighs a minimum of 110 lbs.

  • Baseline heart rate ≥ 45 bpm and ≤ 90 bpm.

  • Blood Pressure: Systolic BP ≤ 140 mmHg and ≥ 90 mmHg, Diastolic BP ≤ 90 mmHg and ≥ 50 mmHg, and if systolic BP is lower than 100 mmHg and/or diastolic BP is lower than 60 mmHg, subject passes an orthostatic blood pressure test.

  • Hemoglobin value ≥ 11 g/dL.

  • CO value ≤ 3.0% FCOHb.

  • Subject can read and communicate in English and understands the study and the risks involved.

Exclusion Criteria (Ineligible Subjects) (* = per clinician discretion):

  • Subject is pregnant or breastfeeding.

  • Subject has a BMI > 35.

  • Subject has a history of fainting (vasovagal syncope), blacking out or losing consciousness during or after a blood draw, or has a fear of blood draws.

  • Subject has open wounds, inflamed tattoos, or piercings, and/or has any visible healing wounds that a medical professional determines may place them at an increased risk for participation. *

  • Subject has finger deformities, nail deformities, nail polish, and/or gel/acrylic that can interfere with study device placement. *

  • Subject has known drug or alcohol abuse.

  • Subject uses recreational drugs. *

  • Subject experiences frequent or severe headaches and/or migraine headaches, migraine auras, altitude sickness, and/or headaches accompanied by visual changes or sensitivity to light or sound.

  • Subject has experienced a concussion or head injury with loss of consciousness within the past 12 months.

  • Subject has any history of a stroke, myocardial infarction (heart attack), and/or seizures.

  • Subject has any chronic bleeding disorder (e.g., hemophilia).

  • Subject has taken anticoagulant medication within the past 30 days (excluding nonsteroidal anti-inflammatory drugs (NSAIDs)).

  • Subject has donated blood within the past 4 weeks.

  • Subject has any cardiac dysrhythmia (e.g., atrial fibrillation) and has not received clearance from their physician to participate.

  • Subject has a known neurological and/or psychiatric disorder (e.g., schizophrenia, bipolar disorder, Multiple Sclerosis, Huntington's disease) that interferes with the subject's level of consciousness. *

  • Subject has taken opioid pain medication 24 hours before the study.

  • Subject has any infectious disease (e.g., Hepatitis, HIV, Tuberculosis, Flu, Malaria, Measles). *

  • Subject is taking medications known to treat any type of infectious disease.

  • Subject has either signs or history of peripheral ischemia or carpal tunnel syndrome.

  • Subject has had invasive surgery within the past year, including but not limited to major dental surgery, appendectomy, plastic surgery, jaw surgery, major ENT surgery, major abdominal and/or pelvic surgery, heart surgery, or thoracic surgery. *

  • Subject has symptoms of congestion, head cold, or other illnesses.

  • Subject has been in a severe car accident(s) or a similar type of accident(s) requiring hospitalization within the past 12 months.

  • Subject has any cancer or history of cancer (not including skin cancer). *

  • Subject has chronic unresolved asthma, lung disease (including COPD) and/or respiratory disease.

  • Subject is allergic to lidocaine, chlorhexidine, latex, adhesives, or plastic.

  • Subject has a heart condition, insulin-dependent diabetes, uncontrolled hypertension, or hypercholesterolemia.

  • Subject delivered vaginally, had a pregnancy terminated, had a miscarriage with hospitalization, or had a C-section within the past 6 months.

  • Subject intends on participating in any heavy lifting, repetitive movement of their wrist (including riding a motorcycle, tennis), exercise (e.g., working out, riding a bike, riding a skateboard), or any activity that will put additional stress on the wrist within 24 hours following a study that involves an arterial line.

  • Difficulty inserting an intravenous line in the subject's hand or arm and/or an arterial line in the radial artery of the subject's wrist.

  • Subject has any medical condition which in the judgment of the investigator and/or medical staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.

Study Design

Total Participants: 24
Treatment Group(s): 1
Primary Treatment: Philips FAST SpO2 with Masimo Pulse Oximetry Sensors
Phase:
Study Start date:
November 13, 2023
Estimated Completion Date:
May 31, 2025

Connect with a study center

  • Masimo Corporation

    Irvine, California 92618
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.